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Katerina Hilari9 , C Elizabeth Lightbody10  
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Abstract
Objective: To evaluate the effect of a dialogue-based intervention targeting psychosocial well-being at 
12 months post-stroke.
Design: Multicenter, prospective, randomized, assessor-blinded, controlled trial with two parallel groups.
Setting: Community.
Subjects: Three-hundred and twenty-two adults (⩾18 years) with stroke within the last four weeks 
were randomly allocated into intervention group (n = 166) or control group (n = 156).
Interventions: The intervention group received a dialogue-based intervention to promote psychosocial 
well-being, comprising eight individual 1–1½ hour sessions delivered during the first six months post-stroke.
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Main measures: The primary outcome measure was the General Health Questionnaire-28 (GHQ-28). 
Secondary outcome measures included the Stroke and Aphasia Quality of Life Scale-39g, the Sense of 
Coherence scale, and the Yale Brown single-item questionnaire.
Results: The mean (SD) age of the participants was 66.8 (12.1) years in the intervention group and 65.7 
(13.3) years in the control group. At 12 months post-stroke, the mean (SE) GHQ-28 score was 20.6 
(0.84) in the intervention group and 19.9 (0.85) in the control group. There were no between-group 
differences in psychosocial well-being at 12 months post-stroke (mean difference: −0.74, 95% confidence 
interval (CI): −3.08, 1.60). The secondary outcomes showed no statistically significant between-group 
difference in health-related quality of life, sense of coherence, or depression at 12 months.
Conclusion: The results of this trial did not demonstrate lower levels of emotional distress and anxiety 
or higher levels of health-related quality of life in the intervention group (dialogue-based intervention) as 
compared to the control group (usual care) at 12 months post-stroke.
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Introduction
Stroke is one of the leading causes of death and 
disability in the adult population worldwide.1 It 
may have a devastating effect on people, not 
only physically, but also emotionally; therefore, 
it is not surprising that psychosocial well-being 
may be threatened following stroke. Depressive 
symptoms, anxiety, general psychological dis-
tress, and social isolation are prevalent.2,3 About 
one-third of stroke survivors report depressive 
symptoms, and 20% report anxiety post-stroke.4,5 
Psychosocial problems persist over time, and the 
prevalence of post-stroke depression remains 
high at 25% in the period from 1 to 5 years post-
stroke.4 Psychosocial difficulties may signifi-
cantly impact long-term functioning and quality 
of life,6,7 reduce the effects of rehabilitation ser-
vices, and lead to higher mortality.8
Despite inconclusive evidence,9,10 targeted 
treatments to promote psychosocial adjustment 
may improve psychosocial well-being.6,11 In our 
work, psychosocial well-being was defined as con-
sisting of a basic mood of contentment, a self-con-
cept characterized by self-acceptance, usefulness, 
and a belief in one’s abilities. Having social rela-
tionships and support, a feeling of loving and being 
loved in relationships are included in the defini-
tion, as well as participation and engagement in 
meaningful activities beyond oneself.12,13 The fea-
sibility work preceding this randomized controlled 
trial (RCT) suggested that it is possible to promote 
psychosocial well-being and coping through a dia-
logue-based intervention.13–15
We hypothesized that a dialogue-based inter-
vention would lead to higher levels of psychoso-
cial well-being expressed through lower levels of 
emotional distress and anxiety at 12 months post-
stroke. Secondary hypotheses were that stroke 
survivors who received the intervention would 
experience significantly higher levels of health-
related quality of life and sense of coherence at 
12 months post-stroke.
Methods
In this study, patient enrollment started in 
November 2014 and concluded data collection in 
November 2017. The Regional Committee for 
Medical and Health Research Ethics, South-East 
(REC no. 2013/2047) and the Data Protection 
Officer serving all participating hospitals (Case 
number: 2014/1026) approved the study. Written 
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informed consent was obtained from all partici-
pants. Due to strict regulations and conditions for 
informed consent enforced by Norwegian law, the 
data set that supports the findings of this study is 
not publicly available. A subset of the data may be 
made available from the corresponding author 
upon reasonable request. The study was registered 
with ClinicalTrials.gov (NCT02338869), and the 
study protocol outlining the full details of the study 
was published in BMC Psychology in 2018.15
The study was a multicenter, prospective, rand-
omized, assessor-blinded, controlled trial with two 
parallel groups (intervention and standard stroke 
treatment) and an equal size allocation ratio of 1:1. 
Eleven hospitals with stroke units or rehabilitation 
centers in South-Eastern Norway enrolled patients. 
Eligible participants were adults aged ⩾18 years, 
had suffered an acute stroke within the last four 
weeks, were medically stable, had sufficient cogni-
tive functioning to participate, were able to under-
stand and speak Norwegian before stroke onset, 
and were able to give informed consent. Exclusion 
criteria were moderate to severe dementia or other 
serious physical or psychiatric diseases and severe 
receptive or expressive aphasia.
The sample size was determined based on 
the primary outcome measure General Health 
Questionnaire-28 (GHQ-28). The calculations 
were based on a repeated measures logistic regres-
sion model of the binary output variable “normal 
mood” (GHQ-28 < 5) with two measurements for 
each patient (i.e. one at six months and one at 
12 months).15 Based on the results of comparable 
studies,11,16 we deemed an odds ratio of 1.6 or 
higher between groups (intervention/control) with 
normal mood after six and 12 months to be clini-
cally relevant. With 80% power across both time 
points and a significance level α at 0.05, the sam-
ple size was estimated to 300 patients (150 per 
group), which was inflated to a total of 330 to 
allow for a potential 10% drop-out.15
A computer-generated block randomization 
procedure with blocks of 10 stratified by hospital 
and with an allocation ratio of 5:5 was used in this 
study. An assistant independent of the research 
team prepared opaque randomization envelopes. 
Two regional trial coordinators carried out the 
allocation following the baseline assessment. 
Participants were informed about group allocation 
immediately. To ensure masking of group alloca-
tion at the follow-up assessments, a message was 
issued from the trial coordinators to participants 
with a reminder not to reveal their group alloca-
tions to the assessors.
The primary and secondary outcomes and meas-
ures are presented in Table 1. The primary outcome 
was psychosocial well-being at 12 months post-
stroke. The GHQ-28 measures symptoms of emo-
tional distress.17,18 In light of the extensive literature 
of the high prevalence of emotional distress fol-
lowing stroke, we assumed that well-being in this 
population would premise the absence of emo-
tional distress. Consequently, in this study, we 
operationalized psychosocial well-being as lower 
levels of emotional distress and used the GHQ-28 
to measure it. For additional details on the scoring 
of the GHQ-28 in this study, please refer to the 
online supplementary material (Supplemental file 
1). Clinical characteristics such as stroke classifi-
cation, side localization of the stroke symptoms, 
stroke severity, cognitive function, and language 
difficulties were assessed at the hospital and were 
collected from the patients’ medical records.
Data were collected in-person via structured 
interviews conducted by trained healthcare profes-
sionals (registered nurses and occupational thera-
pists) at baseline, four to six weeks post-stroke 
(T1), and at six months (T2) and 12 (T3) months 
post-stroke. The data collectors were blinded to 
group allocation. The participants’ ages, sexes, liv-
ing situations, caring responsibilities, previous ill-
nesses and comorbidities, and current rehabilitation 
services were recorded in addition to the structured 
outcome measures.
All participants randomized into the study 
received standard stroke treatment in the acute 
phase according to the Norwegian stroke treatment 
guideline.31 In Norway, patients with minor stroke 
are typically discharged home with access to inter-
disciplinary rehabilitation services in the munici-
pality according to the need and availability of the 
service. Services typically include physical therapy 
and/or occupational therapy and/or speech and lan-
guage therapy and/or home nursing care. Systematic 
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Table 1. Outcomes and measures with scoring and time of assessment.
Measure Description Scoring Assessmenta
Primary outcome
  Psychosocial 
well-being
The General Health 
Questionnaire-28 
(GHQ-28)17,18
Scaled 28-item self-report 
questionnaire measuring 
emotional distress. Four 
subscales identified in 
psychometric tests (somatic 
symptoms, anxiety and 
insomnia, social dysfunction, 
and severe depression).17,19 
Likert scoring, items ranging 
from 1 to 4.
Case scoring, items ranging 
from 0 to 1.
Range sum Likert 
scoring: 0–84, lower 
score indicates lower 
level of distress.
Range sum Case 
scoring: 0–28, cutoff at 
5; <5 indicates normal 
mood, and ⩾5 indicates 
low mood.
T1, T2, T3
Secondary outcomes
  Health-related 
quality of life
Stroke and Aphasia 
Quality of Life 
Scale-39 generic 
stroke version 
(SAQOL-39g)20,21
Self-report 39-item stroke-
specific health-related 
quality-of-life scale. Measures 
patient’s perspective 
of stroke’s impact on 
‘physical’, ‘psychosocial’, and 
‘communication’ domains. 
Likert scoring, items ranging 
from 1 to 5.
Range mean score: 1–5
Higher mean score 
indicates higher 
functioning; higher 
quality-of-life score.
T1, T2, T3
  Sense of 
coherence
Sense of Coherence 
scale (SOC-13)22
Self-report questionnaire, 
13 items measuring the 
main concepts in the sense 
of coherence theory; 
coherence, meaningfulness 
and manageability. Likert 
scoring, ranging from 1 to 5.
Sum range: 13–65.
Higher scores indicate 
a stronger sense of 
coherence.
T1, T2, T3
 Depression The Yale Brown 
single-item 
questionnaire 
(Yale)23,24
Self-reported presence or 
absence of depression
Yes/No T1, T2, T3
Characteristics of 
sample
 
 Fatigue Fatigue 
Questionnaire-2 
(FQ-2)25,26
Self-reported presence or 
absence of fatigue.
If yes; indication of duration 
of symptoms.
Yes/No T1, T2, T3
 Aphasia The Ullevaal 
Aphasia Screening 
Test (UAS)27
Screening for aphasia. 
Based on scores and clinical 
judgment, four categories: 
(1) no language impairment, 
(2) mild language 
impairment, (3) moderate 
language impairment, and (4) 
severe language impairment.
Range 0–52, scores 
<50 indicate pathologic 
language functioning.28
T1
(Continued)
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Measure Description Scoring Assessmenta
  Stroke severity/
neurological 
deficit
National Institutes 
of Health Stroke 
Scale (NIHSS)29
An 11-item scale used by 
healthcare providers to 
objectively quantify the 
impairment caused by a 
stroke.
Range 0–42.
Cutoffs: 0–5 = mild 
symptoms of stroke, 
6–10 = moderate 
symptoms of stroke, 
⩾11 = moderate 
to severe stroke 
symptoms.
T0
  Cognitive 
function
Mini Mental State 
Evaluation (MMSE)30
30-point test that is used to 
measure potential cognitive 
impairment.
Range: 0–30.
Cutoff at 24 to indicate 
cognitive impairment. 
A score below 24 
indicates cognitive 
impairment ranging 
from mild (19–23), 
moderate (10–18), and 
severe (⩽9).
T0
aT0: Data from acute phase collected from patient record; T1: baseline assessment at four to six weeks post-stroke; T2: 
Assessment at six months post-stroke; T3: Assessment at 12 months post-stroke.
Table 1. (Continued)
psychosocial follow-up is rarely part of the services 
provided. Patients with severe stroke are typically 
discharged to a specialized, in-patient rehabilitation 
unit for specialized rehabilitation services.
Participants randomized to the intervention 
group were offered a dialogue-based intervention 
to promote psychosocial well-being. The interven-
tion consisted of eight individual 1–1½-hour ses-
sions between the participants and a specially 
trained nurse or occupational therapist (interven-
tion providers). The intervention providers com-
pleted a three-day training program to learn how to 
guide the sessions and how to work with the par-
ticipants based on the principles outlined in the 
protocol.15 The intervention was delivered in the 
community, primarily in the participants’ homes. 
The same intervention provider worked with each 
participant in all sessions.
In line with the protocol,15 the intervention 
started shortly after randomization; four to eight 
weeks after stroke onset. It lasted 17 weeks, and the 
last session was completed within six months post-
stroke.15,32 A guide of stroke-related topics and 
work-sheets for each session were supplied as part 
of the intervention.15 The intervention provider and 
the participant were encouraged to individually 
adapt the order of topics and the time in-between 
sessions to suit the needs of the participants. 
Additional details on theoretical perspectives 
underpinning the intervention, themes, and content 
of the intervention are outlined in the protocol.15
Implementation fidelity was assessed and previ-
ously published as part of the process evaluation of 
this RCT.32 The assessment of implementation fidel-
ity included a separate analysis of intervention adher-
ence. The composite adherence score showed that 
117 (80.1%) of the intervention trajectories satisfied 
the criteria for high-fidelity intervention adherence.32
Statistical analysis
The data were analyzed using an intention-to-treat 
approach. Missing data were imputed using multiple 
imputations by chained equations in the Statistical 
Package for the Social Sciences (SPSS).33,34 All 
reported results of the statistical analyses were 
pooled across five imputations based on Rubin’s 
rule.35 The statistical software R v3.6.136 with pack-
age mitools v2.4 was used to pool the results across 
all five imputed data sets. For additional details of 
the imputation model, please see the online supple-
mentary material (Supplemental file 2).
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Analyses of the primary and secondary out-
comes were performed using logistic regression 
for binary outcomes and independent and paired 
samples t tests for continuous outcomes. A linear 
mixed model was used to assess the primary out-
come of psychosocial well-being at 12 months 
post-stroke. Due to the complexity of the final 
model, we did not use the dichotomized “normal 
mood” (GHQ-28 < 5) end-point, as it resulted in 
convergence issues when fitting the binary logistic 
mixed model. The continuous sum-score based on 
the Likert-type-scoring of GHQ-28 was used as 
the dependent variable. The other factors of the 
model remained the same as in the predetermined 
statistical analysis plan. The details of the linear 
mixed model are supplied in the online supple-
mentary files (Supplemental file 3).
Statistical tests were performed with SPSS, ver-
sion 25.0 for Windows.37 All statistical tests were 
performed as two-sided tests with a significance 
level of α = 0.05.
Results
The CONSORT flow diagram is presented in 
Figure 1. Three-hundred and fifty-three (58.2%) 
of the eligible individuals consented to participate 
in this study. There were no significant differ-
ences in age and sex between individuals who 
consented and those who did not.19 Between con-
sent and the baseline assessment, 31 (8.8%) par-
ticipants dropped out. Thus, 322 participants were 
assessed at baseline and subsequently allocated to 
the intervention group (n = 166) or the control 
group (n = 156).
Baseline demographics and clinical characteris-
tics are presented in Table 2, and it shows that the 
characteristics were similar in both groups except 
for self-reported depression and stroke classifica-
tion (infarction or hemorrhage).
Results from the between-group comparisons 
at 12 months post-stroke for primary and second-
ary outcomes are presented in Table 3. There 
were no between-group differences in psychoso-
cial well-being at 12 months post-stroke (mean 
difference: −0.74, 95% confidence interval (CI): 
−3.08, 1.60).
The secondary outcomes showed no statistically 
significant between-group difference in depres-
sion, sense of coherence, or health-related quality 
of life at 12 months (Table 3). Self-reported depres-
sion showed no between-group difference at 
12 months (OR: 0.96, 95% CI: 0.55, 1.68). Sense of 
coherence scores appeared to be stable in both 
groups throughout the study trajectory. The overall 
health-related quality of life improved across the 
trajectory, but there was no statistically significant 
difference between the intervention and control 
groups at 12 months (mean difference 0.06, 95% 
CI: −0.04, 0.17; Table 3).
The results of the linear mixed model analysis 
are displayed in Table 4. This analysis showed that 
the fixed effect of time was negative for both six 
months and 12 months, which implies a reduced 
GHQ-28 score overall compared to the baseline, 
indicating a higher level of psychosocial well-
being at six months and 12 months post-stroke rel-
ative to the baseline (Table 4). In addition, five 
other explanatory variables had statistically signifi-
cant fixed effects influencing the GHQ-28 scores.
Higher scores on sense of coherence were asso-
ciated with lower GHQ-28 scores, indicating that 
higher sense of coherence scores were associated 
with higher levels of psychosocial well-being. 
Reporting additional comorbidities, caring respon-
sibilities, fatigue, and depression was associated 
with higher GHQ-28 scores, which indicated lower 
psychosocial well-being. Adjusted for all factors in 
the linear mixed model, the intervention group 
scored lower (mean difference: −0.96 points, 95% 
CI: −2.18, 0.26) on GHQ-28 compared to the con-
trol group; however, the between-group differences 
were not statistically significant (Table 4).
Discussion
Contrary to our hypotheses, the results of this trial did 
not demonstrate at the specified statistical signifi-
cance level that the participants in the intervention 
group experienced higher levels of psychosocial well-
being and lower levels of depressive symptoms and 
anxiety than participants in the control group at 
12 months post-stroke. Nor did the secondary out-
comes show statistically significantly higher levels of 
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Excluded (n= 317)
 Not meeting inclusion criteria (n= 63)
 Declined to participate (n= 211)
Lost to competing studies (n= 12)
 Other reasons (n= 31)
Allocated to intervention (n= 166)
Did not receive allocated intervention (n= 12)
Reasons:
 Due to group allocation (n=4)
 Felt too healthy to participate (n=1)
 Other medical condition (n=2)
 Total burden of rehabilitation (n=1)
 Unavailable after discharge (n=1)
 Did not disclose reason (n=3)
Received intervention (n= 154)
Allocated to control (n= 156)Allocation
Randomized (n= 322)
Enrolment
Eligible, gave consent (n= 353) Drop-out after initial consent (n= 31)
 Missed data collection deadline (n= 8)
 Unavailable after discharge (n= 5)
 Other medical condition (n= 5)
 Did not disclose reason (n= 5)
 Death (n= 4)
 Diagnosis change, not eligible (n= 2)
 Felt overwhelmed (n= 1)
 Felt too healthy to participate (n= 1)
Assessed for eligibility (n= 670)
Lost to follow up (n=11)
 Other medical condition (n=6)
 Total burden of rehabilitation (n=2)
 Unavailable at time of follow-up (n=3)
Follow-up (T2) 
6 months 
Lost to follow up (n=14)
 Due to group allocation (n=2)
 Other medical condition (n=3)
 Unavailable at time of follow-up (n=5)
 Did not wish to disclose reason (n=3)
 Death (n=1)
Follow-up (T3) 
12 months 
Lost to follow up (n=1)
 Unavailable at time of follow-up (n=1)
Lost to follow up (n=2)
 Death (n=2)
Baseline (T1)
4-6 weeks 
Intenon-to-treat analysis (n=166)
Complete cases (n=142)
Intenon-to-treat analysis (n=156)
Complete cases (n=140)
Analysis
Figure 1. CONSORT participant recruitment and retention flow chart.
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Table 2. Baseline demographics and clinical characteristics.
Intervention group (n = 166) Control group (n = 156)
Baseline demographics
 Age, years, mean (SD) 66.8 (12.1) 65.7 (13.3)
 Sex
  Female 67 (40.4) 65 (41.7)
  Male 99 (59.6) 91 (58.3)
 Living conditions
  Living with someone 117 (70.5) 101 (63.7)
  Living alone 49 (29.5) 55 (35.3)
 Have caring responsibilities 37 (22.3) 36 (23.1)
  Underage children 26 (15.7) 22 (14.1)
  Spouse or cohabiting partner 10 (6.0) 6 (3.8)
  Parents 2 (1.2) 6 (3.8)
  Other 2 (1.2) 6 (3.8)
Clinical characteristics
 Stroke classification (n = 147; 144)
  Infarction 128 (87.1) 136 (94.4)
  Hemorrhage 19 (12.9) 8 (5.6)
 Stroke symptom localization (n = 142; 136)
  Right 65 (45.8) 56 (41.2)
  Left 70 (49.3) 74 (54.4)
  Bilateral 7 (4.9) 6 (4.4)
 Communication difficulties (n = 121; 129) 44 (34.1) 42 (34.7)
 Feeling sad or depressed (Yale) 29 (17.5) 43 (27.6)
 Feeling fatigued (FQ-2; n = 165; 156) 88 (53.3) 87 (55.8)
 NIHSS, median (IQR; n = 126; 114) 4 (1–7) 2.5 (1–6)
 NIHSS categorized scores (n = 126; 114)
  Mild (0–5) 85 (67.5) 85 (74.6)
  Moderate (6–10) 28 (22.2) 17 (14.9)
  Moderate to severe (11+) 13 (10.3) 12 (10.5)
 MMSE, median (IQR) (n = 63; 65) 27 (25–29) 28 (26–30)
 UAS (n = 163; 156) median (IQR) 52 (50–52) 52 (50–52)
 Receive one or more rehabilitation services at baseline 114 (68.7) 99 (63.5)
  Physical therapy 98 (59.0) 88 (56.4)
  Occupational therapy 73 (44.0) 62 (39.7)
  Speech and language therapy 30 (18.1) 27 (17.3)
  Home nursing care 56 (33.7) 46 (29.5)
  Psychologist/psychiatrist 14 (8.4) 11 (7.1)
  Other 22 (13.3) 14 (9.0)
 Comorbidities
  No reported comorbidities 31 (18.7) 32 (20.5)
  Hypertension 71 (42.8) 64 (41.0)
  Heart disease 49 (29.5) 39 (25.0)
  Diabetes 22 (13.3) 21 (13.5)
  Stroke 22 (13.3) 25 (16.0)
  Cancer 21 (12.7) 21 (13.5)
(Continued)
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sense of coherence or higher levels of health-related 
quality of life in the intervention group compared 
with the control group at 12 months post-stroke.
In the following, we will highlight possible rea-
sons for the statistically non-significant results in 
this RCT, drawing on the results of a comprehen-
sive process evaluation of the RCT and existing 
research to interpret the outcomes of the trial.32,38 
Plausible explanations may include flaws in the 
underlying theoretical assumptions or characteris-
tics of the intervention, the timing of the interven-
tion, the standard care provided to the intervention 
and control groups, the sample of participants 
enrolled, or the outcome measures.
Based on Antonovsky’s theory of sense of 
coherence,22 we assumed that an important active 
ingredient in the intervention would be to support 
the participants’ perceptions of their lives as 
comprehensible, manageable, and meaningful. 
We anticipated that the intervention would foster 
understanding and re-creation of meaning 
through narrative dialogue and that the interven-
tion provider could support the participants’ cop-
ing efforts and development of new life skills 
through the guided self-determination problem-
solving approach.13,14
Antonovsky framed sense of coherence as a sta-
ble trait that may to some degree be dynamic with 
fluctuations in periods of threatening life events.22 
Others have shown that sense of coherence is less 
stable over time than Antonovsky assumed.39 We 
hypothesized that the intervention would be able to 
influence the participants’ sense of coherence after 
a life-threatening event such as stroke and that a 
higher sense of coherence would lead to higher lev-
els of psychosocial well-being.
This twofold hypothesis was only supported in 
part. The lack of differences within groups over 
time and between the intervention and control 
group does not support the notion that the inter-
vention succeeded in influencing the levels of 
sense of coherence. The results of the study sug-
gest that this intervention did not influence sense 
of coherence and that it is a stable construct. 
However, the results support the notion that a 
higher sense of coherence is important in the pro-
motion of psychosocial well-being.
This knowledge may be important to clinicians 
who need to be able to identify stroke patients who 
need extra attention with regard to promoting psy-
chosocial well-being. It may be advisable to screen 
for sense of coherence during the early post-stroke 
phase to identify those with lower sense of coher-
ence, who may be more vulnerable to lower psy-
chosocial well-being.
Another assumption made in this intervention 
was that it would be possible to prevent depression 
that manifested after stroke due to the increased 
stress and chaos of trying to cope with the post-
stroke changes.3 For some participants, the inter-
vention may have led to decreasing stress and for 
some to potentially increasing it, depending on 
their existing stress levels. If the participants did 
not experience increased stress or challenges in 
coping in this phase of their adjustment process, 
we need to consider if the focus on psychosocial 
Intervention group (n = 166) Control group (n = 156)
  Musculoskeletal diseases 21 (12.7) 22 (14.1)
  Rheumatic diseases 16 (9.6) 15 (9.6)
  Depression 13 (7.8) 16 (10.3)
  Gastrointestinal diseases 12 (7.2) 11 (7.1)
  Lung disease 8 (4.8) 10 (6.4)
  Other reported comorbidities 16 (9.6) 15 (9.6)
SD, standard deviation; IQR, interquartile range; NIHSS, National Institutes of Health Stroke Scale; MMSE, the Mini Mental State 
Exam; UAS, Ulleval Aphasia Screening.
Comorbidities and rehabilitation services were self-reported by participants. Communication difficulties were self-reported and/or 
assessed in the acute phase and recorded in patient records. Values are n (%) unless stated otherwise.
Table 2. (Continued)
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Table 4. Linear mixed model showing fixed effect coefficients.
Coefficient SE 95% CI P-value
Lower Upper
Intercept 54.551 3.472 47.746 61.355 <0.001
Time
 Baseline (Ref.)  
 Six months post-stroke −5.648 0.560 −6.745 −4.551 <0.001
 12 months post-stroke −6.490 0.588 −7.642 −5.338 <0.001
Group allocation
 Control group (Ref.)  
 Intervention group −0.956 0.622 −2.175 0.264 0.125
Sex
 Female (Ref.)  
 Male 0.124 0.647 −1.145 1.393 0.848
Age at admission −0.027 0.024 −0.073 0.019 0.249
Stroke classification
 Infarction (Ref.)  
 Hemorrhage 0.804 1.131 −1.414 3.021 0.477
Stroke symptom localization
 Right (Ref.)  
 Left 0.390 0.673 −0.940 1.719 0.563
 Bilateral 1.433 2.022 −2.539 5.405 0.479
Stroke severity (NIHSS) 0.117 0.097 −0.075 0.309 0.228
Live with partner or other −0.183 0.671 −1.499 1.133 0.785
Comorbidity 1.792 0.716 0.388 3.196 0.012
Rehabilitation services 0.798 0.617 −0.410 2.007 0.195
Caring responsibilities 2.599 0.873 0.889 4.309 0.003
Depression (Yale) 5.514 0.951 3.650 7.377 <0.001
Fatigue (FQ-2) 4.091 0.644 2.829 5.352 <0.001
Sense of coherence (SOC-13) −0.638 0.058 −0.753 −0.524 <0.001
SE, standard error; CI, confidence interval; NIHSS, National Institutes of Health Stroke Scale; FQ, Fatigue Questionnaire; SOC, 
Sense of Coherence scale.
Dependent variable: GHQ-28, sum-score range from 0 to 84 (Likert-type scoring). N = 322.
challenges in the intervention may have increased 
rather than decreased their stress. In the future, 
screening for distress at baseline may be advisable 
in order to explore whether the intervention may be 
more appropriate for those with some level of 
existing stress/distress.
Based on assumptions that early rehabilitation 
efforts are important to promote psychosocial well-
being,3,13 the intervention in this trial was designed 
to be delivered over a period of five months start-
ing four to six weeks post-stroke and concluding 
within six months post-stroke.13,15 The intervention 
period coincides with a period in which spontane-
ous functional recovery may peak40,41 and overlaps 
with a period of comprehensive physical rehabili-
tation within Norwegian stroke services.31 The 
psychosocial intervention provided to the interven-
tion group may not have made a discernable impact 
in this context with substantial rehabilitation efforts 
within the regular healthcare services.
At baseline, participants in both groups reported 
high scores on the Stroke and Aphasia Quality of 
Life Scale-39g (Table 3). Although these scores may 
seem to imply ceiling effects suggesting limited 
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room for improvement, the minimally important dif-
ference on the Stroke and Aphasia Quality of Life 
Scale-39g has been reported as 0.21.42 Therefore, 
despite high baseline scores, there was still room for 
improvement in health-related quality of life in this 
group of participants.
The participants received substantial rehabilita-
tion services as part of their standard stroke treat-
ment. At baseline, 114 (68.7%) participants in the 
intervention group and 99 (63.5%) participants in 
the control group received one or more rehabilita-
tion services, most frequently physical therapy. At 
12 months, the proportion was still high: 70 
(42.3%) participants in the intervention group and 
66 (42.1%) participants in the control group.
Earlier theoretical work has shown that the physi-
cal recovery, daily life adaptation, and normaliza-
tion, as well as biographical adjustment, occurs 
simultaneously throughout the first 12 months of the 
adjustment process after a stroke.41 However, the 
focus on physical recovery is more pronounced in 
the beginning, while the focus on psychosocial 
issues such as biographical adjustment gains empha-
sis later in the trajectory. Introducing this interven-
tion on top of the natural recovery and rehabilitation 
processes may not have added to the adjustment pro-
cess, or the participants may have been more focused 
on other parts of their adjustment than that of a psy-
chosocial nature.
It is important to consider whether the extra 
attention given to the psychosocial issues in the 
intervention group came at an inappropriate time in 
the participants’ stroke recovery and whether we 
may have increased the awareness on psychosocial 
difficulties rather than prevented them. Other stud-
ies have shown successful results in promoting 
normal moods when introducing early psychoso-
cial support by providing motivational interview-
ing to support and build patients’ motivation to 
adjust and adapt to having had a stroke.11
In the study of Watkins and colleagues,11,16 
motivational interviewing aimed to promote self-
efficacy. The patients raised the issues they wanted 
to discuss themselves instead of having topics out-
lined for each meeting.16 Compared to the theoreti-
cal assumptions of anticipated active ingredients of 
the intervention tested in this RCT, motivational 
interviewing may have been more aligned with the 
patients’ phase of adjustment and more aligned 
with their focus on, that is, getting well or frustra-
tion in this early adjustment phase.43 The focus on 
patient-initiated discussion themes rather than the 
pre-specified themes related to psychosocial issues 
may have supported their adjustment to a greater 
degree than in the intervention tested in this RCT.
The feasibility work done during the develop-
ment of the intervention showed that participants 
found the intervention helpful; however, it failed to 
clearly identify specific patient groups who would 
potentially benefit from this intervention.13,14,44,45 
Wide inclusion criteria were applied in the RCT, 
which may have inadvertently resulted in the enrol-
ment of participants who did not particularly need 
this kind of intervention. The process evaluation 
that was conducted alongside the trial showed that 
not all participants expected a personal benefit and 
that a key motivation to participate was to contrib-
ute to research and to help other stroke survivors.38 
Despite this observation, the majority of the par-
ticipants who participated in the qualitative inter-
views as part of the process evaluation found the 
intervention useful and found that it facilitated 
their post-stroke adjustments.38
Some participants in the control group reported 
that the assessment interviews facilitated reflection 
and adjustment, and some indicated that allocation 
to the control group and the themes raised in the 
assessment interviews influenced their help-seeking 
behavior outside the trial.19
It is still important to identify subgroups of the 
stroke population who might benefit from a psycho-
social intervention to promote psychosocial well-
being. Patients who reported depressive symptoms, 
fatigue, comorbidities, and caring responsibilities 
were prone to lower levels of psychosocial well-
being in this study. Earlier studies have shown that 
emotional distress at one month post-stroke, higher 
stroke severity, and communication impairments 
predict emotional distress during the first six months 
post-stroke.46
Studies exploring predictors of emotional dis-
tress and well-being in a longer post-stroke per-
spective have found that higher age (>65 years), 
independence in mobility, having social support, 
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and being employed are important predictors of 
well-being.47 Conversely dependency in activities 
of daily living (i.e. toileting) predict emotional dis-
tress two to five years post-stroke.47 Identifying 
patients with the characteristics identified in this 
and other studies may be especially important in 
clinical settings to identify those who may need 
closer attention and follow-up with regard to psy-
chosocial well-being.
There is a need to consider whether the chosen 
outcome measures were appropriate to detect the 
kind of change the intervention targeted. The change 
in emotional distress in both the intervention and 
control groups across the trajectory indicated that the 
GHQ-28 was sensitive to change. There was a sub-
stantial increase in the proportion of participants with 
GHQ-28 scores <5 in both groups. Furthermore, the 
level of improvement exceeded the findings in a sim-
ilar study in which motivational interviewing was 
provided post-stroke.11,16 However, the sensitivity of 
the GHQ-28 does not necessarily mean it was the 
most suitable outcome measure in this study.
The intervention was aimed at promoting psy-
chosocial well-being. Thus, using an instrument 
that measured breaks in normal function and pres-
ence of emotional distress and reduction in depres-
sive symptoms to enable comparison with similar 
studies may not have been an ideal choice. Including 
a measure that targeted the positive concept of well-
being more directly, such as the Warwick–Edinburgh 
Mental Well-being Scales, could have strengthened 
the study. This scale was developed to enable the 
measuring of mental well-being in the general pop-
ulation and to enable the evaluation of interventions 
that aim to improve mental well-being.48
Based on the definition of psychosocial well-
being used in the development of this intervention, 
including outcome measures that assess participa-
tion in meaningful activities may have added 
important data to evaluate the outcomes of the 
intervention. The lack of such an outcome measure 
was a limitation to this study. Additional outcome 
measures for participation and well-being should 
be explored in future research.
A strength in this study was the systematic 
development and feasibility testing of the interven-
tion prior to full-scale effectiveness tests in this 
RCT.13,14 The trial was conducted in a rigorous 
manner following the Consolidated Standards of 
Reporting Trials (CONSORT) statement.49
In addition, the comprehensive process evalua-
tion, including the evaluation of implementation 
fidelity that was conducted alongside the trial,32 
was an important advantage in documenting the 
trial implementation and in understanding trial 
outcomes.
All intervention providers and assessors partici-
pating in the study were required to complete train-
ing prior to their participation, which was important 
in establishing uniform delivery of the intervention 
and the assessment interviews. Completing inter-
vention sessions with parallel goals of individuali-
zation and uniform delivery may, however, have 
been a limitation in this study. Participating in 
supervision sessions was voluntary for intervention 
providers, and the follow-ups of the assessors were 
also based on a voluntary and as-needed basis. In 
retrospect, mandatory follow-up and supervision 
may have been warranted to assure uniform deliv-
ery of the intervention and uniform assessment 
across the study trajectory.
Another limitation in this study was the difficul-
ties in enrolling patients with more severe stroke 
symptoms and aphasia who were presumably more 
vulnerable to psychosocial problems. However, the 
sample included in this study represents the largest 
group of stroke patients admitted to hospitals in 
Norway.19 The nurses and occupational therapists 
who enrolled participants reported that it was dif-
ficult to assess whether patients with aphasia were 
able to consent. Ensuring an informed consent was 
perceived to be too time-consuming in the clinical 
setting, resulting in few participants with aphasia.
Furthermore, enrolment personnel found it dif-
ficult to approach the patients with more severe 
stroke during the short time that they were treated 
in the stroke unit. These challenges emphasized the 
need for dedicated personnel who were not 
involved in other clinical duties while simultane-
ously enrolling patients to the trial. For future stud-
ies, it may be advisable to enroll patients directly 
from the community and from rehabilitation units 
providing subacute care to reach a broader group of 
patients with more severe impairments.
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This study showed that certain subgroups 
(patients reporting depressive symptoms, fatigue, 
comorbidities, and caring responsibilities) were 
prone to lower levels of psychosocial well-being. 
The results also support the notion that a higher 
sense of coherence is important in the promotion 
of psychosocial well-being. This may inform 
inclusion criteria and screening for certain vul-
nerabilities when enrolling participants in future 
research.
The results in this study suggest that more 
research is needed to explore the relationships 
between psychosocial well-being, sense of coher-
ence, and the process of meaning-making and 
adjustment following an acute stroke. Additional 
mechanisms, such as the impact of resilience 
should be taken into account. Furthermore, explor-
ing these relationships must include the use of 
more adequate instruments to measure psychoso-
cial well-being.
With respect to clinical practice, there is insuf-
ficient evidence to support the implementation of 
the intervention in its current form based on the 
outcome measures used in this RCT. However, the 
inclusion criteria in this study may have been too 
wide, and further research is needed to confirm 
whether certain subgroups of stroke patients may 
benefit from such a psychosocial intervention and 
at what time post-stroke such an intervention may 
be appropriate.
Clinical Messages
•• The dialogue-based intervention imple-
mented in this RCT did not lead to lower 
levels of emotional distress and anxiety at 
12 months post-stroke.
•• The intervention did not lead to higher 
levels of health-related quality of life or 
higher sense of coherence at 12 months 
post-stroke.
•• Based on the outcome measures used in 
this study, there is insufficient evidence to 
support implementation of the intervention 
in its current form.
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